Annals of the New York Academy of Sciences

Number of times cited: 227

• M. Lagarde, M. Hachem, N. Bernoud-Hubac, M. Picq, E. Véricel and M. Guichardant, Biological properties of a DHA-containing structured phospholipid (AceDoPC) to target the brain, Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), 10.1016/j.plefa.2014.01.005, 92, (63-65), (2015).
  Crossref
• Donald J. Hanahan and Susan T. Weintraub, Platelet‐Activating Factor Isolation, Identification, and Assay, Methods of Biochemical Analysis, (195-219), (2006).
  Wiley Online Library
• E. Koch, Inhibition of platelet activating factor (PAF)-induced aggregation of human thrombocytes by ginkgolides: considerations on possible bleeding complications after oral intake of Ginkgo biloba extracts, Phytomedicine, 12, 1-2, (10), (2005).
  Crossref
• I. Jantan, I.A.A. Rafi and J. Jalil, Platelet-activating factor (PAF) receptor-binding antagonist activity of Malaysian medicinal plants, Phytomedicine, 12, 1-2, (88), (2005).
  Crossref
• Ibrahim Jantan, Mazura Pisar, Hasnah Mohd Sirat, Norazah Basar, Shajarahtunnur Jamil, Rasadah Mat Ali and Juriyati Jalil, Inhibitory effects of compounds from Zingiberaceae species on platelet activating factor receptor binding, Phytotherapy Research, 18, 12, (1005-1007), (2005).
  Wiley Online Library
• Yu-Ying Chao and Chung-Ren Jan, Effect of Y-24180 on Ca2+ movement and proliferation in renal tubular cells, Life Sciences, 74, 7, (923), (2004).
  Crossref
• I. Jantan, J. Juriyati and N.A. Warif, Inhibitory effects of xanthones on platelet activating factor receptor binding in vitro, Journal of Ethnopharmacology, 75, 2-3, (287), (2001).
  Crossref
• Mei-Mei Wang, Martha Thomson, Muslim Ali, Cecil R. Pace-Asciak and Jassim M. Al-Hassan, Catfish gel extract causes increase in vascular permeability in the rat skin, InflammoPharmacology, 8, 4, (397), (2000).
  Crossref
• Thanh-Phuong Thai, Claus Rodemer, Jutta Worsch, Andreas Hunziker, Karin Gorgas and Wilhelm W. Just, Synthesis of plasmalogens in eye lens epithelial cells, FEBS Letters, 456, 2, (263-268), (1999).
  Wiley Online Library
• Jenks, Kavanagh, Brooks, Bradfield and Archer, Comparison of weal and flare responses to platelet activating factor (PAF) and histamine, and the ultrastructural effects of PAF in the skin of atopic and normal subjects, Clinical and Experimental Dermatology, 24, 2, (112-117), (2001).
  Wiley Online Library
• Hidekazu Todoroki, Aiichiro Higure, Kohji Okamoto, Keisuke Okazaki, Yukihisa Nagafuchi, Shigeaki Takeda, Hidenori Katoh, Hideaki Itoh, Keiichi Ohsato and Shin Nakamura, Possible Role of Platelet-Activating Factor in thein VivoExpression of Tissue Factor in Neutrophils, Journal of Surgical Research, 80, 2, (149), (1998).
  Crossref
• Angeliki P Karpouza and Catherine Vakirtzi-Lemonias, The platelet-activating factor acetylhydrolase of mouse platelets, Biochimica et Biophysica Acta (BBA) - Biomembranes, 1323, 1, (12), (1997).
  Crossref
• Motohiro Kurosawa, Hideo Tsukagoshi, Yasushi Igarashi and Yoshiki Miyachi, CV6209 inhibits airway wall thickening and airway hyperresponsiveness to histamine induced by intravenous administration of platelet-activating factor in guinea pigs, Journal of Lipid Mediators and Cell Signalling, 13, 2, (139), (1996).
  Crossref
• Burkhard Kleuser, Andreas Meister, Lutz Sternfeld and Guenther Gercken, Measurement of phospholipase A2 and 1-alkylglycerophosphocholine acetyltransferase activities in stimulated alveolar macrophages by HPLC analysis of NBD-labeled ether lipids, Chemistry and Physics of Lipids, 79, 1, (29), (1996).
  Crossref
• F. A. Rodrigues, G. J. Hofmeyr, A. M. Gülmezoĝlu and V. C. Nikodem, Platelet activating factor levels in pre-eclampsia and normal pregnancy, Journal of Obstetrics and Gynaecology, 15, 5, (288), (1995).
  Crossref
• R.Edgardo Catalán, Ana M. Martínez, M.Dolores Aragonés, Manuel Lombardía and Esther Garde, PCA-4248, a PAF receptor antagonist, inhibits PAF-induced phosphoinositide turnover, European Journal of Pharmacology: Molecular Pharmacology, 290, 3, (183), (1995).
  Crossref
• JIH‐HWA GUH, FENG‐NIEN KO, CHIH‐SHONE LEE and CHE‐MING TENG, CSH72—A Specific Antagonist of Platelet‐activating Factor in Rabbit Platelets, Pharmacy and Pharmacology Communications, 1, 11, (525-529), (2011).
  Wiley Online Library
• Hong Yang, Manako Koyanagi, Itsuro Matsumoto, Toshio Shimada, Lin Han and Tadaomi Aikawa, Corticosterone secretion in response to serotonin and acth by perfused adrenal of normal and athymic nude mice, Life Sciences, 56, 20, (1727), (1995).
  Crossref
• Paul Lloyd-Evans, Susan E. Barrow, Darryl J. Hill, Linda A. Bowden, G.Edward Rainger, John Knight and Andrew F. Rowley, Eicosanoid generation and effects on the aggregation of thrombocytes from the rainbow trout, Oncorhynchus mykiss, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1215, 3, (291), (1994).
  Crossref
• E.M. Anastasi, T.H. Williams, G.J. Sasso, D. Chang, D.J. Liberato and A.C. Loh, Disposition and metabolism of Ro 24-4736 in the rat, Life Sciences, 54, 26, (PL483), (1994).
  Crossref
• M.E. ELDERS, M.J.P. GERRITSEN and P.C.M. KERKHOF, The effect of topical application of the platelet‐activating factor‐antagonist, Ro 24‐0238, in psoriasis vulgaris—a clinical and immunohistochemical study, Clinical and Experimental Dermatology, 19, 6, (453-457), (2006).
  Wiley Online Library
• Yoshihiro Yokota, Noriaki Inamura, Masayuki Asano, Yuriko Yamamoto, Kunio Nakahara, Yoshitada Notsu, Takaharu Ono and Minoru Watanabe, Effect of FR128998, a novel PAF receptor antagonist, on endotoxin-induced disseminated intravascular coagulation, European Journal of Pharmacology, 258, 3, (239), (1994).
  Crossref
• Feng-Nien Ko, Sheu-Meei Yu, Ih-Sheng Chen, Hisahi-Ishii, Ya-Ling Chang, Tur-Fu Huang and Che-Ming Teng, CIS-19, a novel platelet activating factor receptor antagonist: In vitro and in vivo studies, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1175, 2, (225), (1993).
  Crossref
• Katsuo Kamata, Yoko Arai and Yutaka Kasuya, Mechanism of the contractile response to Platelet-Activating Factor (PAF) of the rat stomach fundus. I. PAF-induced contractile response and calcium mobilization, General Pharmacology: The Vascular System, 24, 6, (1331), (1993).
  Crossref
• Peter W. Stengel, Alison M. Bendele, Sandra L. Cockerham and Steven A. Silbaugh, Inhaled A23187 Produces a Preferential Sensitization to Substance P, American Review of Respiratory Disease, 147, 1, (196), (1993).
  Crossref
• C.B. ARCHER, Platelet activating factor—a mediator of inflammation in the skin—medical implications, Clinical and Experimental Dermatology, 18, 6, (489-495), (2006).
  Wiley Online Library
• Maria A. TUFANO, Luigi BIANCONE, Fabio ROSSANO, Ciro CAPASSO, Adone BARONI, Antonella MARTINO, Eugenio L. IORIO, Luigi SILVESTRO and Giovanni CAMUSSI, Outer‐membrane porins from Gram‐negative bacteria stimulate platelet‐activating‐factor biosynthesis by cultured human endothelial cells, European Journal of Biochemistry, 214, 3, (685-693), (2005).
  Wiley Online Library
• S. K. Ghosh, P. Rafferty, C. De VOS and K. R. Patel, Effect of cetirizine, a potent H1 antagonist, on platelet activating factor induced bronchoconstriction in asthma, Clinical & Experimental Allergy, 23, 6, (524-527), (2006).
  Wiley Online Library
• Dimitrios Kelefiotis and Catherine Vakirtzi-Lemonias, In vivo responses of mouse blood cells to platelet-activating factor (PAF): Role of the mediators of anaphylaxis, Agents and Actions, 40, 3-4, (150), (1993).
  Crossref
• Jon A. Hotchkiss, Michelle A. Stam and Jack R. Harkema, Platelet Activating Factor Stimulates Rapid Mucin Secretion in Rat Nasal Airways In Vivo, Experimental Lung Research, 19, 5, (545), (1993).
  Crossref
• A. Pintoy, G. Autore, N. Mascolo, R. Sorrentino, A. Biondi, A. A. Izzo and F. Capasso, Time Course of PAF Formation by Gastrointestinal Tissue in Rats After Castor Oil Challenge, Journal of Pharmacy and Pharmacology, 44, 3, (224-226), (2011).
  Wiley Online Library
• H. Miyagawa, M. Nabe, R. J. Hopp, C. Okada, A. K. Bewtra and G. Townley, The effect of WEB 2086 on PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils, Agents and Actions, 37, 1-2, (39), (1992).
  Crossref
• Kazuyuki Noguchi, Ikuo Morita, Isao Ishikawa and Sei-Itsu Murota, Time-dependent Increase of Platelet-activating Factor Acetylhydrolase in the Culture Medium of Mouse Calvaria, Platelets, 3, 1, (23), (1992).
  Crossref
• Toru Sugimoto, Hidetsugu Tsuchimochi, Christopher G.A. McGregor, Hiroyuki Mutoh, Takao Shimizu and Yoshihisa Kurachi, Molecular cloning and characterization of the platelet-activating factor receptor gene expressed in the human heart, Biochemical and Biophysical Research Communications, 189, 2, (617), (1992).
  Crossref
• Filippo Mariano, Ciro Tetta, Giuseppe Montrucchio, Pier Luigi Cavalli and Giovanni Camussi, Role of α1-proteinase inhibitor in restraining peritoneal inflammation in CAPD patients, Kidney International, 42, 3, (735), (1992).
  Crossref
• S.E. Webber, T. Morikawa and J.G. Widdicombe, Platelet‐activating factor relaxes ferret tracheal smooth muscle and reduces transepithelial potential difference in vitro, British Journal of Pharmacology, 105, 1, (223-229), (2012).
  Wiley Online Library
• Jorge Casals-Stenzel, Thieno-triazolo-1,4-diazepines as Antagonists of Platelet-Activating Factor, Platelet-Activating Factor and Structurally Related Alkyl Ehter Lipids, 10.1201/9781439832042.ch38, (1157-1161), (2009).
  Crossref
• H. Okamoto, Y. Iwahisa and M. Terasawa, Suppression of the Arthus reaction by Y-24180, a potent and specific antagonist of platelet-activating factor, Agents and Actions, 35, 3-4, (149), (1992).
  Crossref
• G. M. Kavanagh, B. Archer, G. Morrow, S. O’Loughlin, F. C. Powell, A. B. Ramsay, P. Collins, L. Barnes, C. Buckley, M. Rustin, C. Ivison, L. W. Poulter, K. E. McKenna, E. A. Bingham, M. Walsh, W. H. Irwin, McClean, N. C. Nevin, E. Bonnar, P. Eustace, F. Powell, D. Veale, S. Rogers, G. Yanni, B. Bresnihan and O. Fitzgerald, Royal academy of medicine in Ireland section of dermatology, Irish Journal of Medical Science, 161, 4, (118), (1992).
  Crossref
• Dominique Van Gool, Paul Igodt and Hugo De Cuyper, Mode of action of the triazolobenzodiazepines in the treatment of panic attacks: a hypothesis, European Neuropsychopharmacology, 2, 4, (433), (1992).
  Crossref
• Chandrashekhar R. Gandhi, Michael S. DeBuysere and Merle S. Olson, Platelet-activating factor-mediated synthesis of prostaglandins in rat Kupffer cells, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1136, 1, (68), (1992).
  Crossref
• Feng-Nien Ko, Tian-Shung Wu, Meei-Jen Liou, Tur-Fu Huang and Che-Ming Teng, PAF antagonism in vitro and in vivo by aglafoline from Aglaia elliptifolia Merr, European Journal of Pharmacology, 218, 1, (129), (1992).
  Crossref
• Kazuhiro Tashiro, Zhuoqiu Xie and Yushi Ito, Effects of PAF on excitatory neuro‐effector transmission in dog airways, British Journal of Pharmacology, 107, 4, (956-963), (2012).
  Wiley Online Library
• Tadaomi Aikawa, Taeko Hirose, Itsuro Matsumoto, Toshiko Morikawa, Toshio Shimada, Yumi Mine, Yoshiki Tsujimoto and Yoshiro Tsuji, Effect of platelet‐activating factor on cortisol and corticosterone secretion by perfused dog adrenal, Lipids, 26, 12Part1, (1108-1111), (1991).
  Wiley Online Library
• Jorge Casals‐Stenzel, Thieno‐triazolo‐1,4‐diazepines as antagonists of platelet‐activating factor: Present status, Lipids, 26, 12Part1, (1157-1161), (1991).
  Wiley Online Library
• George B. Kudolo, Mitsunori Kasamo and Michael J. K. Harper, Autoradiographic localization of platelet-activating factor (PAF) binding sites in the rabbit endometrium during the peri-implantation period, Cell & Tissue Research, 265, 2, (231), (1991).
  Crossref
• J.M. Al-Hassan, M. Dyson, S.R. Young, M. Thomson and R.S. Criddle, Acceleration of wound healing responses induced by preparations from the epidermal secretions of the Arabian Gulf catfish (Arius bilineatus, Valenciennes), Journal of Wilderness Medicine, 2, 3, (153), (1991).
  Crossref
• Alaina Jean Ammit and Chris O'Neill, Rapid and selective measurement of platelet-activating factor using a quantitative bioassay of platelet aggregation, Journal of Pharmacological Methods, 26, 1, (7), (1991).
  Crossref
• Giovanni CAMUSSI, Ciro TETTA, Federico BUSSOLINO, Salvatore METAFORA, Gianfranco PELUSO, Carla ESPOSITO and Raffaele PORTA, An anti‐inflammatory protein secreted from the rat seminal vesicle epithelium inhibits the synthesis of platelet‐activating factor and the release of arachidonic acid and prostacyclin, European Journal of Biochemistry, 192, 2, (481-485), (2005).
  Wiley Online Library
• M. LIGUMSKY, M. SESTIERI, F. KARMELI, E. OKON and D. RACHMILEWITZ, The role of platelet activating actor in acute gastric injury and its protection by sucralfate, Alimentary Pharmacology & Therapeutics, 4, 5, (507-514), (2007).
  Wiley Online Library
• Che-Ming Teng, Sheu-Meei Yu, Chien-Chih Chen, Yu-Lin Huang and Tur-Fu Huang, Inhibition of thrombin-and collagen-induced phosphoinositides breakdown in rabbit platelets by a PAF antagonist-denudatin B, an isomer of kadsurenone, Thrombosis Research, 59, 1, (121), (1990).
  Crossref
• Jorge Casals-Stenzel and Hubert O. Heuer, [50] Use of WEB 2086 and WEB 2170 as platelet-activating factor antagonists/at], Arachidonate Related Lipid Mediators, 10.1016/0076-6879(90)87052-5, (455-465), (1990).
  Crossref
• J.Paul Seale, Chemical targeting of drug therapy in asthma and airways disease, Advanced Drug Delivery Reviews, 5, 1-2, (73), (1990).
  Crossref
• Andrew C. Markey, Jonathan N.W.N. Barker, Clive B. Archer, Philippe Guinot, Tak H. Lee and Donald M. MacDonald, Platelet activating factor-induced clinical and histopathologic responses in atopic skin and their modification by the platelet activating factor antagonist BN52063, Journal of the American Academy of Dermatology, 23, 2, (263), (1990).
  Crossref
• Toshiyuki Fukuoka, Yoshiyuki Nakajima, Muneaki Matsumoto, Masakazu Segawa, Hiromichi Kanehiro, Michiyoshi Hisanaga, Takaaki Wada and Hiroshige Nakano, Effect of a platelet activating factor antagonist (CV6209) on shock caused by temporary hepatic inflow occlusion, Life Sciences, 47, 6, (565), (1990).
  Crossref
• M. Terasawa, H. Aratani, M. Setoguchi and T. Tahara, Pharmacological actions of Y-24180: I. A potent and specific antagonist of platelet-activating factor, Prostaglandins, 40, 6, (553), (1990).
  Crossref
• S. J. Konturek, Mechanisms of Gastroprotection, Scandinavian Journal of Gastroenterology, 25, sup174, (15), (1990).
  Crossref
• Mirta Schattner, Angelo Parini, Françoise Fouque, B. Boris Vargaftig and Lhousseine Touqui, Selective inhibition of adrenaline‐induced human platelet aggregation by the structurally related Paf antagonist Ro 19–3704, British Journal of Pharmacology, 96, 4, (759-766), (2012).
  Wiley Online Library
• Robert G. Townley, Russell J. Hopp, Devendra K. Agrawal and Againdra K. Bewtra, Platelet-activating factor and airway reactivity, Journal of Allergy and Clinical Immunology, 83, 6, (997), (1989).
  Crossref
• R.K.G. Assoku and P.R. Gardiner, Detection of antibodies to platelets and erythrocytes during infection with haemorrhage-causing Trypanosoma vivax in ayrshire cattle, Veterinary Parasitology, 31, 3-4, (199), (1989).
  Crossref
• Giuseppe Montrucchio, Filippo Mariano, Pier Luigi Cavalli, Ciro Tetta, Giusto Viglino, Giorgio Emanuelli and Giovanni Camussi, Platelet activating factor is produced during infectious peritonitis in CAPD patients, Kidney International, 36, 6, (1029), (1989).
  Crossref
• Marilena E. Lekka, Demokritos Tsoukatos and Vassilios M. Kapoulas, Uptake of platelet-activating factor (1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine) by Tetrahymena pyriformis, Comparative Biochemistry and Physiology Part B: Comparative Biochemistry, 93, 1, (113), (1989).
  Crossref
• V.L. Leytin, F. Misseiwitz, E.V. Lyubimova and S.P. Domogatsky, The role of platelet prostanoids and dense granule compounds in initial attachment. Spreading and aggregation of platelets on collagen substrates, Thrombosis Research, 55, 4, (395), (1989).
  Crossref
• A. Dembinska-Kiec, B.A. Peskar, M.K. Muller and B.M. Peskar, The effects of platelet-activating factor on flow rate and eicosanoid release in the isolated perfused rat gastric vascular bed, Prostaglandins, 37, 1, (69), (1989).
  Crossref
• M.T. Domingo, P.E. Chabrier, J.L. Van Delft, N.L. Verbeij, N.J. Van Haeringen and P. Braquet, Characterization of specific binding sites for PAF in the iris and ciliary body of rabbit, Biochemical and Biophysical Research Communications, 160, 1, (250), (1989).
  Crossref
• R. Korth, M. Hirafuji, C. Lalau Keraly, D. Delautier, J. Bidault and J. Benveniste, Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells, British Journal of Pharmacology, 98, 2, (653-661), (2012).
  Wiley Online Library
• J.H. Argyroudi-Akoyunoglou and C. Vakirtzi-Lemonias, Enhancement of chlorophyll a fluorescence yield, low-temperature F685F730 fluorescence emission ratio, and electron transport rate by ether phospholipids (platelet activating factor and analogs) in isolated chloroplasts, Archives of Biochemistry and Biophysics, 275, 1, (271), (1989).
  Crossref
• Steven D. Wyrick, Jefferson R. Surles, Susan Morris‐Natschke, Claude Piantadosi and Edward J. Modest, Tritium Labelled 1‐O‐Octadecyl‐2‐O‐methyl‐rac‐glycero‐3‐phosphocholine (ALP) and 1‐S‐Hexadecyl‐2‐O‐ethyl‐rac‐thioglycero‐3‐phosphocholine (Thio‐ALP), Journal of Labelled Compounds and Radiopharmaceuticals, 27, 3, (269-275), (2006).
  Wiley Online Library
• N.J.G. Jansen, W. van Oeveren, Ch.R.H. Wildevuur and M.D. Kazatcnkine, Methylprednisolone inhibits granulocytopenia induced by infusion of complement-activated serum but not of complement-activated plasma in rabbits, Biomaterials, 10, 9, (617), (1989).
  Crossref
• M. J. Bossant, R. Farinotti, F. De Maack, G. Mahuzier, J. Benveniste and E. Ninio, Capillary gas chromatography and tandem mass spectrometry of paf‐acether and analogs: Absence of 1‐O‐alkyl‐2‐propionyl‐sn‐glycero‐3‐phosphocholine in human polymorphonuclear neutrophils, Lipids, 24, 2, (121-124), (1989).
  Wiley Online Library
• F.A. Rodrigues, G.J. Hofmeyr, E.W.W. Sonnendecker and P.M. Atkinson, Hypothesis: A central role for platelet activating factor in the pathogenesis of pre-eclampsia, Medical Hypotheses, 28, 4, (285), (1989).
  Crossref
• K. Noguchi, I. Morita and S. Murota, The detection of platelet-activating factor in inflamed human gingival tissue, Archives of Oral Biology, 34, 1, (37), (1989).
  Crossref
• Lewis J. Smith, Ami-Hai E. Rubin and Roy Patterson, Mechanism of Platelet Activating Factor-induced Bronchoconstriction in Humans, American Review of Respiratory Disease, 137, 5, (1015), (1988).
  Crossref
• Robert L. Wykle, Joseph T. O'Flaherty and Michael J. Thomas, [4] Platelet-activating factor, Immunochemical Techniques Part M: Chemotaxis and Inflammation, 10.1016/0076-6879(88)63006-0, (44-54), (1988).
  Crossref
• F. Magni, G. Rossoni and F. Berti, BN-52021 protects guinea-pig from heart anaphylaxis, Pharmacological Research Communications, 20, (75), (1988).
  Crossref
• J.V. Esplugues and B.J.R. Whittle, Gastric mucosal damage induced by local intra‐arterial administration of Paf in the rat, British Journal of Pharmacology, 93, 1, (222-228), (2012).
  Wiley Online Library
• A. HELLEGOUARCH, M. AUGUET, F. CLOSTRE and P. BRAQUET, Effects of BN 52063 and other agents inhibiting platelet‐activating factor‐induced contractile responses in rat portal vein, Journal of Pharmacy and Pharmacology, 40, 8, (589-591), (2011).
  Wiley Online Library
• B. David, Mastocytes et basophiles, Revue Française d'Allergologie et d'Immunologie Clinique, 28, 3, (213), (1988).
  Crossref
• Clive B. Archer, Fiona M. Cunningham and Malcolm W. Greaves, Actions of Platelet Activating Factor (PAF) Homologues and Their Combinations on Neutrophil Chemokinesis and Cutaneous Inflammatory Responses in Man, Journal of Investigative Dermatology, 91, 1, (82), (1988).
  Crossref
• Peter W. Schindler, Roland Walter and H.Stewart Hendrickson, Fluorophore-labeled ether lipids: Substrates for enzymes of the platelet-activating factor cycle in peritoneal polymorphonuclear leukocytes, Analytical Biochemistry, 174, 2, (477), (1988).
  Crossref
• Sheryl J. Ontell, Leonard Makowka, Peter Ove and Thomas E. Starzl, Improved Hepatic Function in the 24-Hour Preserved Rat Liver With UW-Lactobionate Solution and SRI 63-441, Gastroenterology, 95, 6, (1617), (1988).
  Crossref
• Arun Nagpurkar, Edward Randell, Shibani Choudhury and Sailen Mookerjea, Effect of rat phosphorylcholine-binding protein on platelet aggregation, Biochimica et Biophysica Acta (BBA) - General Subjects, 967, 1, (76), (1988).
  Crossref
• Eduardo Llausas-Magana, Wei Hsueh, Carlos M. Arroyave, Josefa L. Arroyave, Guillermo Torre-Amione and F. Gonzalez-Crussi, Cobra venom factor, an activator of the complement system, enhances the bowel necrosis induced by platelet-activating factor, Immunopharmacology, 15, 1, (31), (1988).
  Crossref
• Sonia Jancar, Grazia De Giaccobi, Mario Mariano, Jean-Michel Mencia-Huerta, Pierre Sirois and Pierre Braquet, Immune complex induced pancreatitis: Effect of BN 52021, a selective antagonist of platelet-activating factor, Prostaglandins, 35, 5, (757), (1988).
  Crossref
• M.G. Sirois, S. Jancar, P. Braquet, G.E. Plante and P. Sirois, PAF increases vascular permeability in selected tissues: Effect of BN-52021 and L-655,240, Prostaglandins, 36, 5, (631), (1988).
  Crossref
• Ruth Korth, Danièle Nunez, Jocelyne Bidault and Jacques Benveniste, Comparison of three paf-acether receptor antagonist ginkgolides, European Journal of Pharmacology, 152, 1-2, (101), (1988).
  Crossref
• Constantinos A. Demopoulos, Nikolaos K. Andrikopoulos and Regina Stathopoulou-Sparou, Abnormal platelet response to PAF and ADP in β-thalassaemia, International Journal of Biochemistry, 20, 6, (599), (1988).
  Crossref
• M Lagarde, Metabolism of fatty acids by platelets and the functions of various metabolites in mediating platelet function, Progress in Lipid Research, 27, 2, (135), (1988).
  Crossref
• Jin Wang, Mark Kester and Michael J. Dunn, The effects of endotoxin on platelet-activating factor synthesis in cultured rat glomerular mesangial cells, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 969, 3, (217), (1988).
  Crossref
• David I. Soybel, Stanley W. Ashley and Laurence Y. Cheung, Effects of platelet-activating factor on canine gastric mucosal blood flow and permeability to luminal acid, The American Journal of Surgery, 155, 1, (180), (1988).
  Crossref
• Katsuhiko Yasuda, Kiyoshi Satouchi, Reiko Nakayama and Kunihiko Saito, Acyl type platelet‐activating factor in normal rat uterus determined by gas chromatography mass spectrometry, Biomedical & Environmental Mass Spectrometry, 16, 1-12, (137-141), (2005).
  Wiley Online Library
• P. D. Gautheron, L. Coulbault and M. F. Sugrue, A study of PAF‐induced ocular inflammation in the rat and its inhibition by the PAF antagonist, L‐652, 731, Journal of Pharmacy and Pharmacology, 39, 10, (857-859), (2011).
  Wiley Online Library
• Ruth Korth and Jacques Benveniste, BN 52021 displaces [3H]paf-acether from, and inhibits its binding to intact human platelets, European Journal of Pharmacology, 142, 3, (331), (1987).
  Crossref
• Fred Snyder, Merle Blank, Ten-ching Lee, Mitchell Robinson and Donna Woodard, Measurement of key enzyme activities involved in the metabolism of platelet activating factor, Cellular Regulators Part B: Calcium and Lipids, 10.1016/0076-6879(87)41085-9, (379-396), (1987).
  Crossref
• San-Bao Hwang, Specific receptor sites for platelet activating factor on rat liver plasma membranes, Archives of Biochemistry and Biophysics, 257, 2, (339), (1987).
  Crossref
• E. R. Pettipher, G. A. Higgs and B. Henderson, PAF-acether in chronic arthritis, Agents and Actions, 21, 1-2, (98), (1987).
  Crossref
• Edward J. Kusner, Cathy D. Knee and Robert D. Krell, Pharmacologic analysis of 1-0-Alkyl-2-Acetyl-sn-Glycero-3-Phosphocholine-induced increases in cutaneous vascular permeability in the rat, Agents and Actions, 20, 1-2, (61), (1987).
  Crossref
• Kenneth B. Adler, Janet E. Schwarz, Wayne H. Anderson and Ann F. Welton, Platelet Activating Factor Stimulates Secretion of Mucin by Explants of Rodent Airways in Organ Culture, Experimental Lung Research, 13, 1, (25), (1987).
  Crossref
• G. Friedlander, E. Pirotzky, C. Amiel and J. Benveniste, Renal effects of platelet-activating factor in the rat, Agents and Actions, 22, 1-2, (165), (1987).
  Crossref
• Jorge Casals-Stenzel, Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock, European Journal of Pharmacology, 135, 2, (117), (1987).
  Crossref
• Ann F. Welton, Margaret O'Donnell and Douglas W. Morgan, The Physiology and Biochemistry of Normal and Diseased Lung, Advances in Clinical Chemistry Volume 26, 10.1016/S0065-2423(08)60325-X, (293-383), (1987).
  Crossref
• C.Frank Bennett, Seymour Mong, Mike A. Clarke, Lawrence I. Kruse and Stanley T. Crooke, Differential effects of manoalide on secreted and intracellular phospholipases, Biochemical Pharmacology, 36, 5, (733), (1987).
  Crossref
• Pieter L.B. Bruijnzeel, Paul T.M. Kok, Maartje L. Hamelink, Arda M. Kijne and Jan Verhagen, Platelet - activating factor induces leukotriene C4 synthesis by purified human eosinophils, Prostaglandins, 34, 2, (205), (1987).
  Crossref
• S. Adnot, D. Joseph and B. B. Vargaftig, Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets, Agents and Actions, 21, 1-2, (195), (1987).
  Crossref
• A.R. Cananzi, F. Ferro‐Milone, F. Grigoletto, M. Toldo, F. Meneghini, F. Bortolon and G. D'Andrea, Relevance of platelet factor four (PF4) plasma levels in multiple sclerosis, Acta Neurologica Scandinavica, 76, 2, (79-85), (2009).
  Wiley Online Library
• Marco Criscuoli and Alessandro Subissi, Paf‐acether‐induced death in mice: involvement of arachidonate metabolites and β‐adrenoceptors, British Journal of Pharmacology, 90, 1, (203-209), (2012).
  Wiley Online Library
• J. Casals‐Stenzel and K.H. Weber, Triazolodiazepines: dissociation of their Paf (platelet activating factor) antagonistic and CNS activity, British Journal of Pharmacology, 90, 1, (139-146), (2012).
  Wiley Online Library
• James P. Codde, Robert Vandongen, Trevor A. Mori, Lawrence J. Beilin and Kathryn J. Hill, CAN THE SYNTHESIS OF PLATELET‐ACTIVATING FACTOR, A POTENT VASODILATOR AND PRO‐AGGREGATORY AGENT, BE ALTERED BY DIETARY MARINE OILS?, Clinical and Experimental Pharmacology and Physiology, 14, 3, (197-202), (2007).
  Wiley Online Library
• R.L. Hebert, P. Sirois, P. Braquet and G.E. Plante, Hemodynamic effects of PAF-Acether on the dog kidney, Prostaglandins, Leukotrienes and Medicine, 26, 3, (189), (1987).
  Crossref
• Naohiko Tamura, Devendra K. Agrawal, Fawzi A. Suliaman and Robert G. Townley, Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects, Biochemical and Biophysical Research Communications, 142, 3, (638), (1987).
  Crossref
• Marco A. Martins, Patrícia M.R. E Silva, Hugo C. Castro, Faria Neto, Marcia C.R. Lima, Renato S.B. Cordeiro and Boris B. Vargaftig, Interactions between local inflammatory and systemic haematological effects of PAF-acether in the rat, European Journal of Pharmacology, 136, 3, (353), (1987).
  Crossref
• Alexandros D. Tselepis, Angelos Evangelou, Democritos Tsoukatos, Constantinos A. Demopoulos and Vassilios M. Kapoulas, Electrocardiographic alterations induced by AGEPC in Wistar rats in relation to its hypotensive and hematologic effects, Comparative Biochemistry and Physiology Part C: Comparative Pharmacology, 87, 1, (41), (1987).
  Crossref
• Hee Yong. Kim and Norman. Salem, Application of thermospray high-performance liquid chromatography/mass spectrometry for the determination of phospholipids and related compounds, Analytical Chemistry, 59, 5, (722), (1987).
  Crossref
• Ami-Hai E. Rubin, Lewis J. Smith and Roy Patterson, The Bronchoconstrictor Properties of Platelet-Activating Factor in Humans, American Review of Respiratory Disease, 136, 5, (1145), (1987).
  Crossref
• Jorge Casals-Stenzel, Effects of WEB 2086, a novel antagonist of platelet activating factor, in active and passive anaphylaxis, Immunopharmacology, 13, 2, (117), (1987).
  Crossref
• John L. Wallace and Brendan J.R. Whittle, Effects of inhibitors of arachidonic acid metabolism on Paf‐induced gastric mucosal necrosis and haemoconcentration, British Journal of Pharmacology, 89, 2, (415-422), (2012).
  Wiley Online Library
• A. J. Lewis, R. P. Carlson, T. J. Forster, J. Chang, J. M. Hand, B. J. Undem, C. K. Buckner, C. Tio, S. F. Sisenwine and W. C. Daniel, The development of Wy-41,195, an orally effective antiallergic drug in animal models, Agents and Actions, 18, 3-4, (306), (1986).
  Crossref
• Merle L. Blank, Arthur A. Spector, Terry L. Kaduce, Ten-ching Lee and Fred Snyder, Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 876, 3, (373), (1986).
  Crossref
• J. Baranes, A. Hellegouarch, M. Le Hegarat, I. Viossat, M. Auguet, P.E. Chabrier and P. Braquet, The effects of PAF-acether on the cardiovascular system and their inhibition by a new highly specific PAF-acether receptor antagonist BN 52021, Pharmacological Research Communications, 18, 8, (717), (1986).
  Crossref
• Giovanni Camussi, Potential role of platelet-activating factor in renal pathophysiology, Kidney International, 29, 2, (469), (1986).
  Crossref
• P. Braquet and J.J. Godfroid, PAF-acether specific binding sites: 2. Design of specific antagonists, Trends in Pharmacological Sciences, 7, (397), (1986).
  Crossref
• J.J. Godfroid and P. Braquet, PAF-acether specific binding sites: 1. quantitative SAR study of PAF-acether isosteres, Trends in Pharmacological Sciences, 7, (368), (1986).
  Crossref
• Teruo Ishibashi and Kuniaki Seyama, Phospholipid requirement of alkylglycerol monooxygenase from rat liver microsomes, Lipids, 21, 3, (1986).
  Wiley Online Library
• Denis B. Buxton, Donald J. Hanahan and Merle S. Olson, Specific antagonists of platelet activating factor-mediated vasoconstriction and glycogenolysis in the perfused rat liver, Biochemical Pharmacology, 35, 6, (893), (1986).
  Crossref
• K.D. Rainsford, Relative roles of leukotrienes and platelet activating factor in experimentally-induced gastric ulceration, Pharmacological Research Communications, 18, (209), (1986).
  Crossref
• John L. Wallace and Brendan J.R. Whittle, Picomole doses of platelet-activating factor predispose the gastric mucosa to damage by topical irritants, Prostaglandins, 31, 5, (989), (1986).
  Crossref
• M. Harczy, J. Maclouf, P. Pradelles, P. Braquet, P. Borgeat and P. Sirois, Inhibitory effects of a novel platelet activating factor (PAF) antagonist (BN 52021) on antigen-induced prostaglandin and thromboxane formation by the guinea pig lung, Pharmacological Research Communications, 18, (111), (1986).
  Crossref
• C. Touvay, A. Etienne and P. Braquet, Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba, Agents and Actions, 17, 3-4, (371), (1986).
  Crossref
• F. Berti, C. Omini, G. Rossoni and P. Braquet, Protection by two ginkgolides, BN-52020 and BN-52021, against guinea-pig lung anaphylaxis, Pharmacological Research Communications, 18, 9, (775), (1986).
  Crossref
• Stéphanie Desquand, Caroline Touvay, Jacques Randon, Vincent Lagente, Beatrice Vilain, Isabelle Maridonneau-Parini, Annie Etienne, Jean Lefort, Pierre Braquet and B. Boris Vargaftig, Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig, European Journal of Pharmacology, 127, 1-2, (83), (1986).
  Crossref
• Davide Lauri, Chiara Cerletti and Giovanni Gaetano, Contribution of ADP to the amplification of primary platelet aggregation by platelet activating factor (PAF): modulatory role of aspirin, Agents and Actions, 17, 5-6, (506), (1986).
  Crossref
• Daniele Nunez, Michel Chignard, Ruth Korth, Jean-Pierre Le Couedic, Xavier Norel, Brigitte Spinnewyn, Pierre Braquet and Jacques Benveniste, Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988, European Journal of Pharmacology, 123, 2, (197), (1986).
  Crossref
• Matyas Koltai, Istvan Lepran, Laszlo Szekeres, Isabelle Viossat, Etienne Chabrier and Pierre Braquet, Effect of BN 52021, a specific PAF-acether antagonist, on cardiac anaphylaxis in Langendorff hearts isolated from passively sensitized guinea-pigs, European Journal of Pharmacology, 130, 1-2, (133), (1986).
  Crossref
• C. Touvar, B. Vilain, J.E. Taylor, A. Etienne and P. Braquet, Proof of the involvement of platelet activating factor (Paf-acether) in pulmonary complex immune systems using a specific Paf-acether receptor antagonist: BN 52021, Progress in Lipid Research, 25, (277), (1986).
  Crossref
• Deirdre N. Robertson and G.M. Smith, CV3988 inhibits in vivo platelet aggregation induced by PAF-acether and collagen, European Journal of Pharmacology, 123, 1, (91), (1986).
  Crossref
• Yoshimi Imura, Zen-ichi Terashita and Kohei Nishikawa, Possible role of platelet activating factor (PAF) in disseminated intravascular coagulation (DIC), evidenced by use of a PAF antagonist, CV-3988, Life Sciences, 39, 2, (111), (1986).
  Crossref
• Sylvie D'Humières, Françoise Russo-Marie and B Boris Vargaftig, PAF-acether-induced synthesis of prostacyclin by human endothelial cells, European Journal of Pharmacology, 131, 1, (13), (1986).
  Crossref
• Ann-Charlotte Rosam, John L. Wallace and Brendan J. R. Whittle, Potent ulcerogenic actions of platelet-activating factor on the stomach, Nature, 319, 6048, (54), (1986).
  Crossref
• Yasuhito Nakagawa, Kazuyuki Fujishima and Keizo Waku, Separation of dimethylphosphatidates of alkylacyl glycerophosphocholine and their molecular species by high-performance liquid chromatography, Analytical Biochemistry, 157, 1, (172), (1986).
  Crossref
• Wei Hsueh, F. Gonzalez-Crussi, Josepha L. Arroyave, Robert C. Anderson, Mark L. Lee and William J. Houlihan, Platelet activating factor-induced ischemic bowel necrosis: The effect of PAF antagonists, European Journal of Pharmacology, 123, 1, (79), (1986).
  Crossref
• K. F. Swingle and M. J. Reiter, Inhibition of Paf-acether-induced Edema of the Rat's Paw, Agents and Actions, 18, 3-4, (359), (1986).
  Crossref
• C. Touvay, B. Vilain, A. Etienne, P. Sirois, P. Borgeat and P. Braquet, Characterization of platelet activating factor (PAF)-acether-induced contractions of guinea-pig lung strips by selected inhibitors of arachidonic acid metabolism and by PAF-acether antagonists, Immunopharmacology, 12, 2, (97), (1986).
  Crossref
• Ed Kloprogge, Paula Hasselaar, Gertie Gorter and Jan-Willem N. Akkerman, Stimulus-aggregation coupling in platelets activated with PAF-acether, Biochimica et Biophysica Acta (BBA) - General Subjects, 883, 1, (127), (1986).
  Crossref
• Fernando Alonso, Peter M. Henson and Christina C. Leslie, A cytosolic phospholipase in human neutrophils that hydrolyzes arachidonoyl-containing phosphatidylcholine, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 878, 2, (273), (1986).
  Crossref
• Philippe Guinot, Pierre Braquet, Jaques Duchier and Antoine Cournot, Inhibition of PAF-acether induced weal and flare reaction in man by a specific PAF antagonist, Prostaglandins, 32, 1, (160), (1986).
  Crossref
• GERALD J. ROTH, Platelet Arachidonate Metabolism and Platelet-Activating Factor, Biochemistry of Platelets, 10.1016/B978-0-12-553240-2.50006-3, (69-113), (1986).
  Crossref
• James G. White and Harvey J. Weiss, Platelet granule disorders, Critical Reviews in Oncology/Hematology, 4, 4, (337), (1986).
  Crossref
• Rahajuningsih Setiabudy-Dharma and Yoshinori Funahara, Enhancement of collagen-induced aggregation of platelets in whole blood, Thrombosis Research, 42, 5, (621), (1986).
  Crossref
• Katsuhiko Yasuda, Kiyoshi Satouchi and Kunihiko Saito, Platelet-activating factor in normal rat uterus, Biochemical and Biophysical Research Communications, 138, 3, (1231), (1986).
  Crossref
• Fred Snyder, Chemical and biochemical aspects of platelet activating factor: A novel class of acetylated ether‐linked choline‐phospholipids, Medicinal Research Reviews, 5, 1, (107-140), (2006).
  Wiley Online Library
• S. N. Khan, J. Belin, A. D. Smith, M. Sidey and K. J. Zilkha, Response to platelet‐activating factor of platelets from patients with multiple sclerosis, Acta Neurologica Scandinavica, 71, 3, (212-220), (2009).
  Wiley Online Library
• Tatsuo Tsuri and Susumu Kamata, An efficient and stereocontrolled synthesis of platelet activating factor from (s)-(−)-malic acid, Tetrahedron Letters, 10.1016/S0040-4039(00)98901-9, 26, 42, (5195-5198), (1985).
  Crossref
• Shah Nawaz Khan, Patricia A. Lane and Anthony D. Smith, Desaggregation of PAF-acether-aggregated platelets by verapamil and TMB-8 with reversal of phosphorylation of 40K and 20K proteins, European Journal of Pharmacology, 107, 2, (189), (1985).
  Crossref
• L. MICHEL and L. DUBERTRET, A simple method for studying chemotaxis, vascular permeability and histological modifications induced by mediators of inflammation in vivo in man, British Journal of Dermatology, 113, s28, (61-66), (2006).
  Wiley Online Library
• P. Braquet, A. Etienne, C. Touvay, R.H. Bourgain, J. Lefort and B.B. Vargaftig, INVOLVEMENT OF PLATELET ACTIVATING FACTOR IN RESPIRATORY ANAPHYLAXIS, DEMONSTRATED BY PAF-ACETHER INHIBITOR BN 52021, The Lancet, 325, 8444, (1501), (1985).
  Crossref
• Luca Parente, Mary Fitzgerald, Gilberto De Nucci and Salvador Moncada, The release of lyso-PAF from guinea-pig lungs, European Journal of Pharmacology, 112, 2, (281), (1985).
  Crossref
• , COMMUNICATIONS, British Journal of Pharmacology, 86, S1, (394P-443P), (2012).
  Wiley Online Library
• A. Detsouli, J. Lefort and B. B. Vargaftig, Histamine and leukotriene‐independent guinea‐pig anaphylactic shock unaccounted for by Paf‐acether, British Journal of Pharmacology, 84, 4, (801-810), (2012).
  Wiley Online Library
• H. C. Wimberly, D. O. Slauson and N. R. Neilsen, Functional and Biochemical Characterization of Immunologically Derived Equine Platelet-Activating Factor, Veterinary Pathology, 22, 4, (375), (1985).
  Crossref
• Bertrand Hanin, Marie-Germaine Bousser, Jes Olesen, Boris B. Vargaftig, Kai Jensen and Bo Jacobson, Platelet Aggregation Study in Migraine Patients between and during Attacks, Cephalalgia, 5, 3_suppl, (398), (1985).
  Crossref
• L. Parente and R.J. Flower, Hydrocortisone and ‘macrocortin’ inhibit the zymosan-induced release of lyso-PAF from rat peritoneal leucocytes, Life Sciences, 36, 13, (1225), (1985).
  Crossref
• Daniel J. Lenihan, Neil Greenberg and Lee Ten-Ching, Involvement of platelet activating factor in physiological stress in the lizard, Anolis carolinensis, Comparative Biochemistry and Physiology Part C: Comparative Pharmacology, 81, 1, (81), (1985).
  Crossref
• P. O. Ogunbiyi and P. Eyre, Pharmacological studies of pulmonary anaphylaxisin vitro: A review, Agents and Actions, 17, 2, (158), (1985).
  Crossref
• Reiko Nakayama, Makoto Oda, Kiyoshi Satouchi and Kunihiko Saito, Generation of acetyl glyceryl ether phosphorylcholine from the rat skin and muscle tissues stimulated by moxibustion, Biochemical and Biophysical Research Communications, 127, 2, (629), (1985).
  Crossref
• Manfred Steiner, Raffaele Landolfi, Nancy C. Motola and Joseph G. Turcotte, Biological activity of Platelet Activating Factor-amidophosphonate (PAF-AP), a novel phosphonolipid selective inhibitor of platelet activating factor (PAF), Biochemical and Biophysical Research Communications, 133, 3, (851), (1985).
  Crossref
• Maria Nikolopoulou, Donald A. Soucek and James C. Vary, Changes in the lipid content of boar sperm plasma membranes during epididymal maturation, Biochimica et Biophysica Acta (BBA) - Biomembranes, 815, 3, (486), (1985).
  Crossref
• Lhousseine Touqui, Claude Jacquemin, Claude Dumarey and B.Boris Vargaftig, 1-O-Alkyl-2-acyl-sn-glycero-3-phosphorylcholine is the precursor of platelet-activating factor in stimulated rabbit platelets. Evidence for an alkylacetyl-glycerophosphorylcholine cycle, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 833, 1, (111), (1985).
  Crossref
• R.H. Bourgain, L. Maes, P. Braquet, R. Andries, L. Touqui and M. Braquet, The effect of 1-O-alkyl-2-acetyl-Sn-glycero- 3-phosphocholine (paf-acether) on the arterial wall, Prostaglandins, 30, 2, (185), (1985).
  Crossref
• Eng Lay Tan and Fred Snyder, Metabolism of platelet activating factor (1-alkyl-2-acetyl--glycero-3-phosphocholine) by capillary endothelial cells isolated from rat epididymal adipose tissue, Thrombosis Research, 38, 6, (713), (1985).
  Crossref
• Nakagawa Yasuhito, Sugiura Takayuki and Waku Keizo, The molecular species composition of diacyl-, alkylacyl- and alkenylacylglycerophospholipids in rabbit alveolar macrophages. High amounts of 1-O-hexadecyl-2-arachidonyl molecular species in alkylacylglycerophosphocholine, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 833, 2, (323), (1985).
  Crossref
• M.L. Wardlow, Rapid isocratic procedure for the separation of platelet-activating factor from phospholipids in human saliva by high-performance liquid chromatography, Journal of Chromatography B: Biomedical Sciences and Applications, 342, (380), (1985).
  Crossref
• C. John Blankley and Harvey R. Kaplan, Biologically active phospholipids as potential cardiovascular drugs, Drug Development Research, 4, 3, (351-372), (2004).
  Wiley Online Library
• A. Dewar, C. B. Archer, W. Paul, C. P. Page, D. M. Macdonald and J. Morley, Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf‐acether) in the guinea‐pig, The Journal of Pathology, 144, 1, (25-34), (2005).
  Wiley Online Library
• Merle L. Blank, Edgar A. Cress and Fred Snyder, A new class of antihypertensive neutral lipid: 1-Alkyl-2-acetyl-sn-glycerols, a precursor of platelet activating factor, Biochemical and Biophysical Research Communications, 118, 1, (344), (1984).
  Crossref
• G. Ostermann, U. Till and K. Thielmann, Cooperative effects of 1-O-alkyl-2-O-acetyl--glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets, Thrombosis Research, 33, 4, (409), (1984).
  Crossref
• C.P. Cox, J. Linden and S.I. Said, VIP elevates platelet cyclic AMP (cAMP) levels and inhibits in vitro platelet activation induced by platelet-activating factor (PAF), Peptides, 5, 2, (325), (1984).
  Crossref
• J.M. Lynch, G.S. Worthen and P.M. Henson, Platelet-activating factor, Development of Anti-Asthma Drugs, 10.1016/B978-0-408-11576-6.50009-7, (73-88), (1984).
  Crossref
• J. V. Levy and D. Trinh, Immunoreactive calmodulin in supernatant fraction of platelet homogenates from humans, guinea pigs, rats, and rabbits, Archives Internationales de Physiologie et de Biochimie, 92, 2, (85), (1984).
  Crossref
• G. S. BASRAN, C. P. PAGE, W. PAUL and J MORLEY, Platelet‐activating factor: a possible mediator of the dual response to allergen?, Clinical & Experimental Allergy, 14, 1, (75-79), (2006).
  Wiley Online Library
• C. B. ARCHER, C. P. PAGE, W. PAUL, J. MORLEY and D. M. MACDONALD, Inflammatory characteristics of platelet activating factor (PAF-acether) in human skin, British Journal of Dermatology, 110, 1, (45), (1984).
  Crossref
• P. Braquet, R. F. Vidal, M. Braquet, H. Hamard and B. B. Vargaftig, Involvement of leukotrienes and PAF-acether in the increased microvascular permeability of the rabbit retina, Agents and Actions, 15, 1-2, (82), (1984).
  Crossref
• Sushila Krishnamurthi, John Westwick and Vijay V. Kakkar, Regulation of human platelet activation—Analysis of cyclooxygenase and cyclic AMP-dependent pathways, Biochemical Pharmacology, 33, 19, (3025), (1984).
  Crossref
• A. J. Lewis, A. Dervinis and J. Chang, The effects of antiallergic and bronchodilator drugs on platelet-activating factor (PAF-acether) induced bronchospasm and platelet aggregation, Agents and Actions, 15, 5-6, (636), (1984).
  Crossref
• F. Fouque and B.B. Vargaftig, Triggering by Paf‐acether and adrenaline of cyclo‐oxygenase‐independent platelet aggregation, British Journal of Pharmacology, 83, 3, (625-633), (2012).
  Wiley Online Library
• J. Lefort, D. Rotilio and B.B. Vargaftig, The platelet‐independent release of thromboxane A2 by Paf‐acether from guinea‐pig lungs involves mechanisms distinct from those for leukotriene, British Journal of Pharmacology, 82, 3, (565-575), (2012).
  Wiley Online Library
• G. Mallarkey and G.M. Smith, In vivo platelet aggregation in the rat: dependence on extracellular divalent cation and inhibition by nonsteroidal anti‐inflammatory drugs, British Journal of Pharmacology, 81, 1, (31-39), (2012).
  Wiley Online Library
• Eduardo Pirotzky, Jocelyne Bidault, Claude Burtin, Marie Claire Gubler and Jacques Benveniste, Release of platelet-activating factor, slow-reacting substance, and vasoactive amines from isolated rat kidneys, Kidney International, 25, 2, (404), (1984).
  Crossref
• Damian V. McGivern and Gurnam S. Basran, Synergism between platelet-activating factor (PAF-acether) and prostaglandin E2 in man, European Journal of Pharmacology, 102, 1, (183), (1984).
  Crossref
• Michel Chignard, Jean-Pierre Le Couedic, Eliane Coëffier and Jacques Benveniste, Paf-acether formation and arachidonic acid freeing from platelet ether-linked glyceryl-phosphorylcholine, Biochemical and Biophysical Research Communications, 124, 2, (637), (1984).
  Crossref
• Daniel H. Albert and Fred Snyder, Release of arachidonic acid from 1-ALKYL-2-ACYL-sn-glycero-3-phosphocholine, a precursor of platelet-activating factor, in sat alveolar macrophages, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 796, 1, (92), (1984).
  Crossref
• W. Paul, C. P. Page, F. M. Cunningham and J. Morley, The plasma protein extravasation response to PAF-acether is independent of platelet accumulation, Agents and Actions, 15, 1-2, (80), (1984).
  Crossref
• Daniel J. Lenihan and Ten-Ching Lee, Regulation of platelet activating factor synthesis: Modulation of 1-alkyl-2-lyso-sn-glycero-3-phosphocholine:Acetyl-CoA acetyltransferase by phosphorylation and dephosphorylation in rat spleen microsomes, Biochemical and Biophysical Research Communications, 120, 3, (834), (1984).
  Crossref
• L. Touqui, M. Chignard, C. Jacquemin, F. Wal and B. B. Vargaftig, Dissociation between inhibition of phospholipid methylation and production of PAF-acether by rabbit platelets, Experientia, 40, 4, (374), (1984).
  Crossref
• J. Morley, C.P. Page and W. Paul, Inflammatory actions of platelet activating factor (Paf‐acether) in guinea‐pig skin, British Journal of Pharmacology, 80, 3, (503-509), (2012).
  Wiley Online Library
• Iftekhar Alam, J.B. Smith and Melvin J. Silver, Human and rabbit platelets form platelet-activating factor in response to calcium ionophore, Thrombosis Research, 30, 1, (71), (1983).
  Crossref
• W. Paul and C. P. Page, Cutaneous responses to synthetic platelet activating factor (PAF-acether) in the guinea-pig, Agents and Actions, 13, 5-6, (455), (1983).
  Crossref
• Lhossein Touqui, Claude Jacquemin and Bernardo Boris Vargaftig, Conversion of 3H-PAF acether by rabbit platelets is independent from aggregation: Evidences for a novel metabolite, Biochemical and Biophysical Research Communications, 110, 3, (890), (1983).
  Crossref
• Merle L. Blank, Marvin N. Hall, Edgar A. Cress and Fred Snyder, Inactivation of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by a plasma acetylhydrolase: Higher activities in hypertensive rats, Biochemical and Biophysical Research Communications, 113, 2, (666), (1983).
  Crossref
• C. Lecrubier, J. Conard, M. H. Horellou and M. Samama, Study of platelet aggregation induced by platelet activating factor (PAF) after administration of ticlopidine or aspirin, Agents and Actions, 13, 1, (77), (1983).
  Crossref
• C.P. Page and J. Morley, Chemotactic factors of inflammation, Trends in Pharmacological Sciences, 4, (449), (1983).
  Crossref
• Alan J. Lewis, Robert J. Capetola and James A. Mezick, Chapter 19. Pharmacological Developments in Dermatology, , 10.1016/S0065-7743(08)60774-5, (181-192), (1983).
  Crossref
• , COMMUNICATIONS, British Journal of Pharmacology, 80, S1, (426P-594P), (2012).
  Wiley Online Library
• Adam Myers, Estelle Ramey and Peter Ramwell, Glucocorticoid protection against PAF‐acether toxicity in mice, British Journal of Pharmacology, 79, 2, (595-598), (2012).
  Wiley Online Library
• , POSTER COMMUNICATIONS, British Journal of Pharmacology, 78, S1, (88P-184P), (2012).
  Wiley Online Library
• Joseph V. Levy, Calmodulin antagonists inhibit aggregation of human, guinea pig and rabbit platelets induced with platelet activating factor, FEBS Letters, 154, 2, (262-264), (2001).
  Wiley Online Library
• , POSTER COMMUNICATIONS, British Journal of Pharmacology, 79, S1, (274P-423P), (2012).
  Wiley Online Library
• R.C. Anderson and R.C. Nabinger, Synthesis of a novel platelet activating factor congener from diacetone glucose, Tetrahedron Letters, 24, 27, (2741), (1983).
  Crossref
• Howard W. Mueller, A. David Purdon, J. Bryan Smith and Robert L. Wykle, 1‐O‐alkyl‐linked phosphoglycerides of human platelets: Distribution of arachidonate and other acyl residues in the ether‐linked and diacyl species, Lipids, 18, 11, (814-819), (1983).
  Wiley Online Library
• Roger H. Lumb, Gary L. Pool, Dulce G. Bubacz, Merle L. Blank and Fred Snyder, Spontaneous and protein-catalyzed transfer of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) between phospholipid bilayers, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 750, 2, (217), (1983).
  Crossref
• Ewa Ninio, Jean Michel Mencia-Huerta and Jacques Benveniste, Biosynthesis of platelet-activating factor (paf-acether), Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 751, 3, (298), (1983).
  Crossref
• E. Kloprogge, G.H. de Haas, G. Gorter and J.W.N. Akkerman, Properties of PAF-acether-induced platelet aggregation and secretion. Studies in gel-filtered human platelets, Thrombosis Research, 29, 6, (595), (1983).
  Crossref
• M.L. Blank and Fred Snyder, Improved high-performance liquid chromatographic method for isolation of platelet-activating factor from other phospholipids, Journal of Chromatography B: Biomedical Sciences and Applications, 273, 2, (415), (1983).
  Crossref
• Fred Snyder, Chapter 24. Platelet Activating Factor (PAF), A Novel Type of Phospholipid with Diverse Biological Properties, , 10.1016/S0065-7743(08)60506-0, (243-252), (1982).
  Crossref
• G.H.R. Rao and J.G. White, Platelet activating factor (paf) causes human platelet aggregation through the mechanism of membrane modulation, Prostaglandins, Leukotrienes and Medicine, 9, 4, (459), (1982).
  Crossref
• Hidetaka Ieyasu, Yoshimi Takai, Kozo Kaibuchi, Makoto Sawamura and Yasutomi Nishizuka, A role of calcium-activated, phospholipid-dependent protein kinase in platelet-activating factor-induced serotonin release from rabbit platelets, Biochemical and Biophysical Research Communications, 108, 4, (1701), (1982).
  Crossref
• B.Boris Vargaftig, Françoise Fouque, Jacques Benveniste and Jacques Odiot, Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets, Thrombosis Research, 28, 4, (557), (1982).
  Crossref
• G.S. Basran, C.P. Page, W. Paul and J. Morley, Cromoglycate (DSCG) inhibits responses to platelet-activating factor (PAF-acether) in man: An alternative mode of action for DSCG in asthma?, European Journal of Pharmacology, 86, 1, (143), (1982).
  Crossref
• , POSTER COMMUNICATIONS, British Journal of Pharmacology, 77, S1, (340P-443P), (2012).
  Wiley Online Library
• Robert L. Wykle, Jefferson R. Surles, Claude Piantadosi, William L. Salzer and Joseph T. O'Flaherty, Platelet activating factor (1‐O‐alkyl‐2‐O‐acetyl‐sn‐glycero‐3‐phosphocholine), FEBS Letters, 141, 1, (29-32), (2001).
  Wiley Online Library
• Arthur Prancan, Jean Lefort, Mary Barton and B. Boris Vargaftig, Relaxation of the guinea-pig trachea induced by platelet-activating factor and by serotonin, European Journal of Pharmacology, 80, 1, (29), (1982).
  Crossref
• B.B. Vargaftig, Platelet activation by non-coagulant snake venom components, Toxicon, 20, 1, (279), (1982).
  Crossref
• J Benveniste, M Chignard, J.P Le Couedic and B.B Vargaftig, Biosynthesis of platelet-activating factor (PAF-acether) II. Involvement of phospholipase A2 in the formation of PAF-acether and lyso-PAF-acether from rabbit platelets, Thrombosis Research, 25, 5, (375), (1982).
  Crossref
• Myles C. Cabot, Merle L. Blank, Clement J. Welsh, Michael J. Horan, Edgar A. Cress and Fred Snyder, Metabolism of 1-alkyl-2-acetyl--glycero-3-phosphocholine by cell cultures, Life Sciences, 31, 25, (2891), (1982).
  Crossref
• Jennifer M. Hanson, Vivian M. Rumjanek and John Morley, Mediators of cellular immune reactions, Pharmacology & Therapeutics, 17, 2, (165), (1982).
  Crossref
• J. Lefort, F. Wal, M. Chignard, M. C. Medeiros and B. B. Vargaftig, Pharmacological properties of PAF-acether in the guinea-pig: Platelet-dependent and independent reactions, Agents and Actions, 12, 5, (723), (1982).
  Crossref
• B. B. Vargaftig, Editorial, Agents and Actions, 12, 5, (699), (1982).
  Crossref
• E. Lanara, C. Vakirtzi-Lemonias, L. Kritikou and C.A. Demopoulos, Response of mice and mouse platelets to acetyl glyceryl ether phosphorylcholine, Biochemical and Biophysical Research Communications, 109, 4, (1148), (1982).
  Crossref